REPORT ID 3181

Global Histone Deacetylase(HDAC) Inhibitors Market Professional Survey Report 2017

Publish Date
12-Dec-17
Pages
119
Format
Electronic (PDF)

This report studies Histone Deacetylase(HDAC) Inhibitors in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Gloucester Pharmaceuticals
    Spectrum Pharmaceuticals
    Pharmacyclics
    Ventana Medical Systems
    Signal Rx
    SpeBio
    Quimatryx
    TetraLogic Pharmaceuticals
    Onyx
    Mirati Therapeutics
    Karus Therapeutics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Hydroxamic Acids
    Cyclic Tetrapeptides
    Benzamides
    Electrophilic Ketones
    Aliphatic Acid

By Application, the market can be split into
    Psychiatry and Neurology
    Cancer Treatment
    HIV
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Histone Deacetylase(HDAC) Inhibitors Market Professional Survey Report 2017
1 Industry Overview of Histone Deacetylase(HDAC) Inhibitors
    1.1 Definition and Specifications of Histone Deacetylase(HDAC) Inhibitors
        1.1.1 Definition of Histone Deacetylase(HDAC) Inhibitors
        1.1.2 Specifications of Histone Deacetylase(HDAC) Inhibitors
    1.2 Classification of Histone Deacetylase(HDAC) Inhibitors
        1.2.1 Hydroxamic Acids
        1.2.2 Cyclic Tetrapeptides
        1.2.3 Benzamides
        1.2.4 Electrophilic Ketones
        1.2.5 Aliphatic Acid
    1.3 Applications of Histone Deacetylase(HDAC) Inhibitors
        1.3.1 Psychiatry and Neurology
        1.3.2 Cancer Treatment
        1.3.3 HIV
        1.3.4 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Histone Deacetylase(HDAC) Inhibitors
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Histone Deacetylase(HDAC) Inhibitors
    2.3 Manufacturing Process Analysis of Histone Deacetylase(HDAC) Inhibitors
    2.4 Industry Chain Structure of Histone Deacetylase(HDAC) Inhibitors

3 Technical Data and Manufacturing Plants Analysis of Histone Deacetylase(HDAC) Inhibitors
    3.1 Capacity and Commercial Production Date of Global Histone Deacetylase(HDAC) Inhibitors Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Histone Deacetylase(HDAC) Inhibitors Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Histone Deacetylase(HDAC) Inhibitors Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Histone Deacetylase(HDAC) Inhibitors Major Manufacturers in 2016

4 Global Histone Deacetylase(HDAC) Inhibitors Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Histone Deacetylase(HDAC) Inhibitors Capacity and Growth Rate Analysis
        4.2.2 2016 Histone Deacetylase(HDAC) Inhibitors Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Histone Deacetylase(HDAC) Inhibitors Sales and Growth Rate Analysis
        4.3.2 2016 Histone Deacetylase(HDAC) Inhibitors Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Histone Deacetylase(HDAC) Inhibitors Sales Price
        4.4.2 2016 Histone Deacetylase(HDAC) Inhibitors Sales Price Analysis (Company Segment)

5 Histone Deacetylase(HDAC) Inhibitors Regional Market Analysis
    5.1 North America Histone Deacetylase(HDAC) Inhibitors Market Analysis
        5.1.1 North America Histone Deacetylase(HDAC) Inhibitors Market Overview
        5.1.2 North America 2012-2017E Histone Deacetylase(HDAC) Inhibitors Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Histone Deacetylase(HDAC) Inhibitors Sales Price Analysis
        5.1.4 North America 2016 Histone Deacetylase(HDAC) Inhibitors Market Share Analysis
    5.2 China Histone Deacetylase(HDAC) Inhibitors Market Analysis
        5.2.1 China Histone Deacetylase(HDAC) Inhibitors Market Overview
        5.2.2 China 2012-2017E Histone Deacetylase(HDAC) Inhibitors Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Histone Deacetylase(HDAC) Inhibitors Sales Price Analysis
        5.2.4 China 2016 Histone Deacetylase(HDAC) Inhibitors Market Share Analysis
    5.3 Europe Histone Deacetylase(HDAC) Inhibitors Market Analysis
        5.3.1 Europe Histone Deacetylase(HDAC) Inhibitors Market Overview
        5.3.2 Europe 2012-2017E Histone Deacetylase(HDAC) Inhibitors Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Histone Deacetylase(HDAC) Inhibitors Sales Price Analysis
        5.3.4 Europe 2016 Histone Deacetylase(HDAC) Inhibitors Market Share Analysis
    5.4 Southeast Asia Histone Deacetylase(HDAC) Inhibitors Market Analysis
        5.4.1 Southeast Asia Histone Deacetylase(HDAC) Inhibitors Market Overview
        5.4.2 Southeast Asia 2012-2017E Histone Deacetylase(HDAC) Inhibitors Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Histone Deacetylase(HDAC) Inhibitors Sales Price Analysis
        5.4.4 Southeast Asia 2016 Histone Deacetylase(HDAC) Inhibitors Market Share Analysis
    5.5 Japan Histone Deacetylase(HDAC) Inhibitors Market Analysis
        5.5.1 Japan Histone Deacetylase(HDAC) Inhibitors Market Overview
        5.5.2 Japan 2012-2017E Histone Deacetylase(HDAC) Inhibitors Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Histone Deacetylase(HDAC) Inhibitors Sales Price Analysis
        5.5.4 Japan 2016 Histone Deacetylase(HDAC) Inhibitors Market Share Analysis
    5.6 India Histone Deacetylase(HDAC) Inhibitors Market Analysis
        5.6.1 India Histone Deacetylase(HDAC) Inhibitors Market Overview
        5.6.2 India 2012-2017E Histone Deacetylase(HDAC) Inhibitors Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Histone Deacetylase(HDAC) Inhibitors Sales Price Analysis
        5.6.4 India 2016 Histone Deacetylase(HDAC) Inhibitors Market Share Analysis

6 Global 2012-2017E Histone Deacetylase(HDAC) Inhibitors Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Histone Deacetylase(HDAC) Inhibitors Sales by Type
    6.2 Different Types of Histone Deacetylase(HDAC) Inhibitors Product Interview Price Analysis
    6.3 Different Types of Histone Deacetylase(HDAC) Inhibitors Product Driving Factors Analysis
        6.3.1 Hydroxamic Acids of Histone Deacetylase(HDAC) Inhibitors Growth Driving Factor Analysis
        6.3.2 Cyclic Tetrapeptides of Histone Deacetylase(HDAC) Inhibitors Growth Driving Factor Analysis
        6.3.3 Benzamides of Histone Deacetylase(HDAC) Inhibitors Growth Driving Factor Analysis
        6.3.4 Electrophilic Ketones of Histone Deacetylase(HDAC) Inhibitors Growth Driving Factor Analysis
        6.3.5 Aliphatic Acid of Histone Deacetylase(HDAC) Inhibitors Growth Driving Factor Analysis

7 Global 2012-2017E Histone Deacetylase(HDAC) Inhibitors Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Histone Deacetylase(HDAC) Inhibitors Consumption by Application
    7.2 Different Application of Histone Deacetylase(HDAC) Inhibitors Product Interview Price Analysis
    7.3 Different Application of Histone Deacetylase(HDAC) Inhibitors Product Driving Factors Analysis
        7.3.1 Psychiatry and Neurology of Histone Deacetylase(HDAC) Inhibitors Growth Driving Factor Analysis
        7.3.2 Cancer Treatment of Histone Deacetylase(HDAC) Inhibitors Growth Driving Factor Analysis
        7.3.3 HIV of Histone Deacetylase(HDAC) Inhibitors Growth Driving Factor Analysis
        7.3.4 Others of Histone Deacetylase(HDAC) Inhibitors Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Histone Deacetylase(HDAC) Inhibitors
    8.1 Gloucester Pharmaceuticals
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Gloucester Pharmaceuticals 2016 Histone Deacetylase(HDAC) Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Gloucester Pharmaceuticals 2016 Histone Deacetylase(HDAC) Inhibitors Business Region Distribution Analysis
    8.2 Spectrum Pharmaceuticals
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Spectrum Pharmaceuticals 2016 Histone Deacetylase(HDAC) Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Spectrum Pharmaceuticals 2016 Histone Deacetylase(HDAC) Inhibitors Business Region Distribution Analysis
    8.3 Pharmacyclics
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Pharmacyclics 2016 Histone Deacetylase(HDAC) Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Pharmacyclics 2016 Histone Deacetylase(HDAC) Inhibitors Business Region Distribution Analysis
    8.4 Ventana Medical Systems
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Ventana Medical Systems 2016 Histone Deacetylase(HDAC) Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Ventana Medical Systems 2016 Histone Deacetylase(HDAC) Inhibitors Business Region Distribution Analysis
    8.5 Signal Rx
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Signal Rx 2016 Histone Deacetylase(HDAC) Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Signal Rx 2016 Histone Deacetylase(HDAC) Inhibitors Business Region Distribution Analysis
    8.6 SpeBio
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 SpeBio 2016 Histone Deacetylase(HDAC) Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 SpeBio 2016 Histone Deacetylase(HDAC) Inhibitors Business Region Distribution Analysis
    8.7 Quimatryx
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Quimatryx 2016 Histone Deacetylase(HDAC) Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Quimatryx 2016 Histone Deacetylase(HDAC) Inhibitors Business Region Distribution Analysis
    8.8 TetraLogic Pharmaceuticals
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 TetraLogic Pharmaceuticals 2016 Histone Deacetylase(HDAC) Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 TetraLogic Pharmaceuticals 2016 Histone Deacetylase(HDAC) Inhibitors Business Region Distribution Analysis
    8.9 Onyx
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Onyx 2016 Histone Deacetylase(HDAC) Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Onyx 2016 Histone Deacetylase(HDAC) Inhibitors Business Region Distribution Analysis
    8.10 Mirati Therapeutics
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Mirati Therapeutics 2016 Histone Deacetylase(HDAC) Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Mirati Therapeutics 2016 Histone Deacetylase(HDAC) Inhibitors Business Region Distribution Analysis
    8.11 Karus Therapeutics

9 Development Trend of Analysis of Histone Deacetylase(HDAC) Inhibitors Market
    9.1 Global Histone Deacetylase(HDAC) Inhibitors Market Trend Analysis
        9.1.1 Global 2017-2022 Histone Deacetylase(HDAC) Inhibitors Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Histone Deacetylase(HDAC) Inhibitors Sales Price Forecast
    9.2 Histone Deacetylase(HDAC) Inhibitors Regional Market Trend
        9.2.1 North America 2017-2022 Histone Deacetylase(HDAC) Inhibitors Consumption Forecast
        9.2.2 China 2017-2022 Histone Deacetylase(HDAC) Inhibitors Consumption Forecast
        9.2.3 Europe 2017-2022 Histone Deacetylase(HDAC) Inhibitors Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Histone Deacetylase(HDAC) Inhibitors Consumption Forecast
        9.2.5 Japan 2017-2022 Histone Deacetylase(HDAC) Inhibitors Consumption Forecast
        9.2.6 India 2017-2022 Histone Deacetylase(HDAC) Inhibitors Consumption Forecast
    9.3 Histone Deacetylase(HDAC) Inhibitors Market Trend (Product Type)
    9.4 Histone Deacetylase(HDAC) Inhibitors Market Trend (Application)

10 Histone Deacetylase(HDAC) Inhibitors Marketing Type Analysis
    10.1 Histone Deacetylase(HDAC) Inhibitors Regional Marketing Type Analysis
    10.2 Histone Deacetylase(HDAC) Inhibitors International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Histone Deacetylase(HDAC) Inhibitors by Region
    10.4 Histone Deacetylase(HDAC) Inhibitors Supply Chain Analysis

11 Consumers Analysis of Histone Deacetylase(HDAC) Inhibitors
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Histone Deacetylase(HDAC) Inhibitors Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source